P. Swinburn

TL;DR: The EQ-5D-5L appears to be a valid extension of the 3-level system which improves upon the measurement properties, reducing the ceiling while improving discriminatory power and establishing convergent and known-groups validity.

TL;DR: This study has developed and valuing a disease-specific "bolt-on" version of the EQ-5D questionnaire to support future psoriasis research and has informed the development of future bolt-on versions of this generic measure.

TL;DR: Practical constraints coupled with the societal nature of the valuation exercise limited the amount of direct involvement by patients, however, these utility values should better permit the consideration of toxicity profiles in establishing the cost-effectiveness of future treatments.

TL;DR: Findings indicate that self-reported adherers to UC therapy have a stronger preference for clinical benefits over other treatment attributes, suggesting that positive patient assessment of effectiveness may influence adherence.

TL;DR: There is significant potential value in developing self-injection devices that are not only efficacious but also convenient and comfortable to use and reducing barriers to adherence could potentially translate into improved treatment outcomes for patients with MS.